Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02650583 · ClinicalTrials.gov registry record · NA

Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children

A NA study of Advanced Malignant Neoplasm, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
41
Enrollment target
1
Study location

NCT02650583 is a NA study of Advanced Malignant Neoplasm that has completed, run by University of Washington. The registered enrollment target is 41 participants, below the 174-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02650583, a NA study of Advanced Malignant Neoplasm, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
41 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication with their children and help them to cope with their parent's incurable cancer.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Educational Intervention

Study Locations (1)

Washington

  • Fred Hutch/University of Washington Cancer Consortium - Seattle

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2015-12-28
Est. Completion 2018-02-15
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT02650583

The ClinicalTrials.gov registry entry for NCT02650583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 174-participant average among 16 other Advanced Malignant Neoplasm trials with a reported enrollment target (76% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT02650583 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT02650583 about?

NCT02650583 is a clinical study titled "Enhancing Connections Program in Improving Communication Between Patients With Incurable Cancer and Their Children". This pilot clinical trial studies the use of the Enhancing Connections Program in improving communication between patients with incurable cancer and their children. The Enhancing Connections Program is an educational program that may provide patients with new competencies to improve communication wi...

What is the current status of trial NCT02650583?

This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-12-28. Estimated completion is 2018-02-15.

What conditions does trial NCT02650583 study?

This clinical trial studies the following conditions: Advanced Malignant Neoplasm.

What interventions are being tested in trial NCT02650583?

The interventions under investigation include: Questionnaire Administration (OTHER), Educational Intervention (OTHER).

Who is sponsoring clinical trial NCT02650583?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02650583 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.